Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IFN-lambda therapy: current status and future perspectives
Ahmed Lasfar, Andrew Zloza, Karine Cohen-Solal
Drug Discovery Today (2015) Vol. 21, Iss. 1, pp. 167-171
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Transcriptional Regulation of Antiviral Interferon-Stimulated Genes
Wenshi Wang, Lei Xu, Junhong Su, et al.
Trends in Microbiology (2017) Vol. 25, Iss. 7, pp. 573-584
Open Access | Times Cited: 175
The host genetics affects gut microbiome diversity in Chinese depressed patients
Ke Han, Lei Ji, Chenliu Wang, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 13
Interferon Lambda: Toward a Dual Role in Cancer
Ahmed Lasfar, Andrew Zloza, Ann W. Silk, et al.
Journal of Interferon & Cytokine Research (2018) Vol. 39, Iss. 1, pp. 22-29
Closed Access | Times Cited: 39
Identification of a Predominantly Interferon-λ-Induced Transcriptional Profile in Murine Intestinal Epithelial Cells
T. Selvakumar, Sudeep Bhushal, Ulrich Kalinke, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 35
Activation of type I interferon antiviral response in human neural stem cells
Jhao‐Yin Lin, Rei‐Lin Kuo, Hsing‐I Huang
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 34
Rotavirus Strategies Against the Innate Antiviral System
Susana López, Liliana Sánchez-Tacuba, Joaquín Moreno-Contreras, et al.
Annual Review of Virology (2016) Vol. 3, Iss. 1, pp. 591-609
Open Access | Times Cited: 32
Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-λ in vitro and in mice
Lucie Sauerhering, Alexandra Kupke, Lars Meier, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 5, pp. 1901826-1901826
Open Access | Times Cited: 28
Hepatitis D virus: Improving virological knowledge to develop new treatments
Pierre Khalfi, Patrick T. Kennedy, Karim Majzoub, et al.
Antiviral Research (2022) Vol. 209, pp. 105461-105461
Open Access | Times Cited: 16
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases—Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway
Chiara Massa, Yuan Wang, Nico Marr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6736-6736
Open Access | Times Cited: 10
Infection-Simulator, Immunostimulatory and Immunomodulatory Effects of Interferons I and III in Biological Systems: A New Era in Vaccinology and Therapeutics Possible?
Theodor-Nicolae Carp, Michael Metoudi, Vanshika Ojha
(2024)
Open Access | Times Cited: 3
Infection-Simulator, Immunostimulatory and Immunomodulatory Effects of Interferons I and III in Biological Systems: A New Era in Vaccinology and Therapeutics Possible?
Theodor-Nicolae Carp, Michael Metoudi, Vanshika Ojha
(2024)
Open Access | Times Cited: 3
Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship
Giulia Finotti, Nicola Tamassia, Marco A. Cassatella
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 30
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells
Alessandra Fragale, Giulia Romagnoli, Valerio Licursi, et al.
Cancer Immunology Research (2017) Vol. 5, Iss. 7, pp. 604-616
Open Access | Times Cited: 29
The Interplay between Host Immunity and Respiratory Viral Infection in Asthma Exacerbation
Ferdaus Mohd Altaf Hossain, Jin‐Young Choi, Erdenebileg Uyangaa, et al.
Immune Network (2019) Vol. 19, Iss. 5
Open Access | Times Cited: 29
IFN-λ: A New Inducer of Local Immunity against Cancer and Infections
Ahmed Lasfar, Andrew Zloza, Andrew de la Torre, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 27
Roles and Effects of Interferon Lambda Signaling in the Context of Bacterial Infections
Da’Kuawn Johnson, Nicholas H. Carbonetti
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 9, pp. 363-369
Open Access | Times Cited: 8
Chronic hepatitis D—What is changing?
David Yardeni, Theo Heller, Christopher Koh
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 4, pp. 240-251
Closed Access | Times Cited: 13
Drug repurposing clinical trials in the search for life-saving COVID-19 therapies; research targets and methodological and ethical issues
Francisco José Roma Paumgartten, Isabella Fernandes Delgado, Luciana da Rocha Pitta, et al.
Vigilância Sanitária em Debate (2020) Vol. 8, Iss. 2, pp. 39-53
Open Access | Times Cited: 15
Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency
Jae‐Hee Chung, Seon-Hui Hong, Nari Seo, et al.
Cytokine (2019) Vol. 125, pp. 154833-154833
Open Access | Times Cited: 14
The Unresolved Role of Interferon-λ in Asthma Bronchiale
Nina Sopel, Andreas Pflaum, Julia Kölle, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 13
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
Chiara Medaglia, Arnaud Charles‐Antoine Zwygart, Paulo Jacob Silva, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1196-1196
Open Access | Times Cited: 11
The immune-adjunctive potential of recombinant LAB vector expressing murine IFNλ3 (MuIFNλ3) against Type A Influenza Virus (IAV) infection
Sandeep Yadav, Aparna Varma, Aparna Odayil Muralidharan, et al.
Gut Pathogens (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Beyond bulevirtide: Alternative therapeutic options for the management of hepatitis delta virus
Tarik Asselah
Journal of Viral Hepatitis (2022) Vol. 30, Iss. S1, pp. 34-39
Open Access | Times Cited: 4
Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data
Henriette Huschka, Sabine Mihm
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus
Dong‐Hwi Kim, Byung‐Joo Park, Hee‐Seop Ahn, et al.
Virus Research (2021) Vol. 296, pp. 198342-198342
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top